Goldman Sachs gives its verdict on the Altium share price

Should you be buying this tech share?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Altium Limited (ASX: ALU) share price is trading lower on Tuesday.

In afternoon trade, the electronic design software company's shares are down 1% to $35.95.

This means the Altium share price is now down approximately 20% in 2022.

Two men look excited on the trading floor as they hold telephones to their ears and one points upwards.

Image source: Getty Images

Is the Altium share price weakness a buy opportunity?

Goldman Sachs has been looking at Altium this week and has given its verdict on the company's shares.

According to the note, while the broker only initiated coverage on the company's shares with a neutral rating, it does see plenty of value in them at the current level.

Goldman has initiated with a price target of $42.00, which implies potential upside of almost 17% for investors. It commented:

Altium is seeing strong momentum from its flagship, desktop based software, Altium Designer, while has significant monetisation opportunities as it transitions this to the cloud (365) and fully leverages its #1 electronic parts marketplace Octopart.

Bull and bear cases

Goldman also revealed that it sees scope for the Altium share price to rise to $66 in its bull case scenario and fall as low as $29 in its bear case scenario.

The broker explained the bull case scenario:

Our Bull case scenario factoring in: Pathway to US$500mn FY26 revenues at 40% EBITDA margins (in-line with targets), and a corresponding re-rating in ALU's multiple to 49x, which reflects the median growth adjusted multiple of profitable ANZ Tech Peers (1.9x) and the stronger EBITDA growth (+25% FY22-25E CAGR). We do not include an M&A valuation given an acceleration in earnings would likely extend the premium past its peak vs. ANZ technology peers (which is the basis of our 15% base case M&A Valuation).

As for the bear case scenario, it said:

Our Bear case scenario assumes: difficult PCB subscription growth given business uncertainty (10% B&S Rev CAGR) supported by solid pricing, a normalisation in the outlook for Octopart post Covid supply chain tailwinds (11% Rev CAGR), with modest margin expansion, and a corresponding lower fundamental multiple of 22x driving an A$26 fundamental valuation, based on the growth adj. EBITDA multiple of ANZ Technology peers (1.9x) and the softer growth outlook (11% EBITDA CAGR). This fundamental valuation (85% weighting) and a 15% weighting of a M&A valuation of A$48 derived from a lower earnings expectation on 42x EV/EBITDA (in-line with base case), gives an overall bear case valuation of A$29.

Based on the above, the next few years are likely to be very interesting and potentially very rewarding for investors if things go to plan.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Altium. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Time to sell written on a clock.
Broker Notes

Sell alert! Why this expert is calling time on Westpac and CBA shares

A leading expert forecasts growing headwinds for Westpac and CBA shares.

Read more »

Man looking at digital holograms of graphs, charts, and data.
Broker Notes

Expert names 2 ASX tech shares to buy today

A top analyst says these two ASX tech stocks are well-positioned to outperform.

Read more »

A female ASX investor looks through a magnifying glass that enlarges her eye and holds her hand to her face with her mouth open as if looking at something of great interest or surprise.
Broker Notes

4 ASX All Ords shares with 40% to 90% upside post-results: experts

These shares have major upside potential, according to the experts.

Read more »

Woman looking at a laptop and thinking.
Broker Notes

4 ASX shares scoring upgrades in the final week of earnings season

Brokers have increased their ratings on Sigma Healthcare, Adairs, Netwealth, and other shares.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Buy, hold, sell: Netwealth, Sigma Healthcare, and Wesfarmers shares

The team at Morgans has given its verdict on these shares.

Read more »

Smiling kid flexing his muscles.
Broker Notes

3 ASX 200 shares to buy post-results: broker

Morgans has reviewed these companies' FY26 reports and given them a buy rating.

Read more »

Small kid giving a thumbs up.
Broker Notes

9 ASX 200 shares with strengthened buy ratings this week

Brokers are positive on Paladin Energy, Coles, WiseTech, Centuria Capital, and other shares.

Read more »

A couple in a supermarket laugh as they discuss which fruits and vegetables to buy
Broker Notes

Buy, hold, sell: Ramsay Health Care, PLS Group, Woolworths shares

Morgans has updated its ratings and 12-month price targets on these 3 ASX 200 shares.

Read more »